Orthomed Partners with Osso VR, Bringing First-of-its-Kind VR Training to Veterinary Care

Orthomed, a member of the Infiniti Medical family, announces today a partnership with Osso VR, the leading virtual reality-based surgical training company, officially bringing RoVR™ surgical training to the animal health market. This first-of-its-kind training technology allows for veterinarians to practice procedures anytime, anywhere in VR. The goal of this partnership is for Orthomed and its parent company, Infiniti Medical, to offer a full content library of veterinary procedures using Osso VR’s technology.

Already widely adopted in the medical industry, Osso VR’s on-demand, educational experiences are effective, repeatable, and measurable to help veterinarians reach proficiency with emerging techniques and medical devices. Utilizing this technology, veterinarians will have access to VR training to gain muscle memory for increasing performance, knowledge and confidence in various procedures. Allowing veterinarians to experience and practice a procedure in VR before performing it on an animal increases the chances for a positive outcome.

“RoVR™ is a valuable new resource for veterinarians to gain exposure and practice in performing surgeries. There is a growing body of evidence which shows that repeated  participation in VR training leads to increased confidence and more effective clinical outcomes for our pets,” said Jared Finegold, CEO of Infiniti Medical-Orthomed. “We are proud to be the first animal health company offering VR training technology to veterinarians worldwide.”

The first VR module being released is for cruciate ligament repair surgery using OrthoMed’s Canine Cruciate Repair System. The surgery is a common and mainstream canine procedure that occurs when the dog has a tear in their cruciate ligaments, located in the knee. The surgery provides re-stabilization of the knee to help them regain their mobility.

“Osso VR offers the opportunity to train and assess yourself on any procedure in VR  in order to learn new procedures, and to maintain your proficiency on existing ones.  I’m incredibly excited that we can expand our evidence-backed technology into veterinary care for the first time ever by partnering with Infiniti Medical-Orthomed, a leader in the animal health technology space .” said Justin Barad MD, CEO and co-founder of Osso VR.

Osso VR’s platform boasts an exceptional level of visual fidelity, ensuring every aspect of surgery, from anatomical detail to the OR environment, enhances the training experience.  In addition, the technology is proven to significantly impact surgical performance.  In two recent level 1 randomized peer-reviewed studies, surgeons training with Osso VR showed anywhere from a 230 percent to 306 percent improvement in overall surgical performance compared to traditional training. In addition, Osso VR enables healthcare professionals, including veterinarians, to  train together in VR from anywhere in the world through Remote Collaboration.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.